Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanchang UniversityActive in the last 2 years

Rongfa Yuan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8204-0839; OpenAlex author ID A5035565117. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 7

  1. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Last author DOI 10.1186/s13578-024-01213-9↗
  2. SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. Co-author DOI 10.1038/s41388-023-02843-y↗
  3. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression. Last author DOI 10.1038/s41419-022-04960-0↗
  4. Nano-drug delivery system for pancreatic cancer: A visualization and bibliometric analysis. Last author DOI 10.3389/fphar.2022.1025618↗
  5. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα. First author DOI 10.1038/s41388-020-01527-1↗
  6. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1. Co-author DOI 10.1038/s41419-021-04163-z↗
  7. Deubiquitinase USP18 promotes the progression of pancreatic cancer via enhancing the Notch1-c-Myc axis. Co-author DOI 10.18632/aging.103760↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Leifeng Chen · 5 shared papers, 2021–2024 · strength 0.77
  2. Chen Huan Luo · 2 shared papers, 2022–2024 · strength 0.34
  3. Jinfeng Zhu · 2 shared papers, 2022–2024 · strength 0.34
  4. Jiefeng Zhao · 2 shared papers, 2022 · strength 0.31
  5. Fanqin Bu · 2 shared papers, 2022 · strength 0.31
  6. Yunyan Du · 2 shared papers, 2021–2023 · strength 0.29
  7. Xueqiang Deng · 2 shared papers, 2021–2023 · strength 0.29
  8. Xiaogang Peng · 2 shared papers, 2021 · strength 0.28
  9. Xin Yu · 2 shared papers, 2020–2022 · strength 0.24
  10. Zhengming Zhu · 1 shared paper, 2022 · strength 0.17
  11. Ben Che · 1 shared paper, 2023 · strength 0.15
  12. Wenming Zhang · 1 shared paper, 2023 · strength 0.15
  13. Long Feng · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.